New
HealthMore in Health→
Remdesivir tied to better long-term outcomes in kidney transplant patients with COVID-19
Key Takeaways
- A Johns Hopkins-led study examined 432 adult kidney transplant recipients diagnosed with COVID-19 from 2020 to 2024.
- Patients who received remdesivir within a week of diagnosis for at least three consecutive days had better long-term outcomes.
- The reported benefit extended to lower risk of cardiovascular or kidney problems over the following year.
- The findings add evidence for a population often excluded from randomized trials.
DE
DT Editorial Team··via medicalxpress.com